Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_provenance.
• NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_provenance.
• NP476454.RAQnOwmFXb1KkKpjOWWX3NQqvQoUM4PQzDBirYN9K_tm0130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476454.RAQnOwmFXb1KkKpjOWWX3NQqvQoUM4PQzDBirYN9K_tm0130_provenance.
• NP607385.RASLT0D0uWW6P0SaCbBo8VEnQDWukl-ukKDVZfbyO957I130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607385.RASLT0D0uWW6P0SaCbBo8VEnQDWukl-ukKDVZfbyO957I130_provenance.
• NP320365.RA-7EYVpK64XVaGkVxdORBJTwWdFVx-BW1kZ8P--yGm6E130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320365.RA-7EYVpK64XVaGkVxdORBJTwWdFVx-BW1kZ8P--yGm6E130_provenance.
• NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207492.RANc_YMS_bDL0n7V55Kp56wY7BH1kwfN0Wm_AnAI9M5ic130_provenance.
• NP434105.RAeHnnC-Sjr4chQaB05FDhAgDmzjIsdvQ1r002f3t7BIQ130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434105.RAeHnnC-Sjr4chQaB05FDhAgDmzjIsdvQ1r002f3t7BIQ130_provenance.
• NP551978.RA0YHZzDDYnXYBV73usfXMBJAE0tzLx3VM4vFJVeGC_WI130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551978.RA0YHZzDDYnXYBV73usfXMBJAE0tzLx3VM4vFJVeGC_WI130_provenance.
• assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP459114.RAJsf4ThNLMDF7JCwGZD5EHbUiMMo4Eo8utMHfrph3NI0130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP459114.RAJsf4ThNLMDF7JCwGZD5EHbUiMMo4Eo8utMHfrph3NI0130_provenance.